MAKING THE CASE FOR FRACTURE LIAISON SERVICES IN PREVENTION OF DISABILITY - ANALYSIS OF NATIONAL PRESCRIBING DATA IN ENGLAND
PHE ePoster Library. Doyle A. Sep 12, 2017; 186558; 4
Ali Doyle
Ali Doyle
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Abstract BACKGROUNDThe National Osteoporosis Society (NOS) service development team supports establishment of Fracture Liaison Services (FLS) across the UK for the prevention of secondary fractures. The NOS supports sites to demonstrate clinical and cost-effectiveness to payors from business case to post-implementation evaluation. Studies show that half of hip fractures occur after a prior fragility fracture, and 25% of hip fractures could be prevented with identification, treatment and advice on lifestyle risk factors. Fracture prevention is cost-effective in terms of both social and healthcare budgets; and at a person level, prevents disability. This analysis sought to demonstrate whether prescribing data could be used as an indicator of FLS effectiveness. METHODSAn analysis was conducted of all prescriptions of osteoporosis medication in England over 44 months using public data on osteoporosis medications prescribed in general practice [https://openprescribing.net]. Data was collated with registered populations allowing comparison of prescribing rates. The data were analysed to:determine national trends in the treatment of osteoporosis.demonstrate the impact of FLS.Specific case studies were drawn out where illustrative.RESULTS The analysis showed a statistically significant downward trend in national prescribing of osteoporosis treatments. Where a FLS was well established, prescribing rates rose after inception, going against the national trend. Where a FLS was decommissioned, a rapid decrease in prescribing rates was observed. CONCLUSIONDemonstrating clinical and cost-effectiveness is important in the current climate of constrained spending for publicly-funded health services. Prescribing data, which is readily available and reliable, can be an asset in meeting this challenge.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings